RegEd
RegEd Launches Producer Management and Licensing Automation Technology Bundle for Midsized Insurers and Distributors
February 15, 2024 12:30 ET | RegEd
Raleigh, NC, Feb. 15, 2024 (GLOBE NEWSWIRE) -- RegEd, the leading provider of producer management solutions for the insurance and financial services industry, has announced the launch of a...
Numab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancer
February 14, 2024 03:00 ET | Numab Therapeutics AG
NM49 is a multi-specific antibody identified through Numab’s proprietary discovery and engineering technology platform designed to activate tumor associated macrophage phagocytosis Numab to receive...
greylogo.png
VitalHub Announces First Canadian Licensing Agreement of the Award-Winning Intouch with Health Queue Management & Patient Journey Optimization Platform with Newfoundland & Labrador Health Services
February 12, 2024 07:30 ET | VitalHub Corp.
TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the "Company" or "VitalHub") (TSX:VHI) (OTCQX:VHIBF) is pleased to announce the first Canadian customer for the Intouch with Health Queue...
CryoMass Technologies Inc.
CryoMass Announces Non-Dilutive Financing Agreement
January 29, 2024 07:10 ET | Cryomass Technologies
CryoMass Announces Non-Dilutive Financing Agreement
Travere-TxTM-Inline-fullcolor.png
Travere Therapeutics Announces Licensing Agreement with Renalys Pharma to Develop and Commercialize Sparsentan in Japan, South Korea, Taiwan, and Southeast Asian Nations
January 25, 2024 16:05 ET | Travere Therapeutics, Inc.
Travere Therapeutics has entered into an exclusive licensing agreement with Renalys Pharma to bring sparsentan to patients in Japan.
TSplus Challenges the One-Size-Fits-All Approach to Licensing Amidst Citrix Policy Changes
January 12, 2024 09:11 ET | TSplus
Amidst Citrix's significant shift towards a subscription-based model, TSplus makes the choice of flexibility when it comes to licensing models.
SERMONIX NEW LOGO JPEG (2).jpg
Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene
January 10, 2024 19:30 ET | Sermonix Pharmaceuticals Inc.
Partnership expands Henlius’ portfolio with license of exclusive China rights to develop, manufacture and commercialize lasofoxifene; Sermonix retains all other global rightsHenlius to facilitate...
abaxx logo.png
Abaxx Granted Approved Clearinghouse and Recognised Market Operator Licenses from Monetary Authority of Singapore
December 07, 2023 08:45 ET | Abaxx Technologies Inc.
TORONTO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (NEO:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of...
Adeia Logo.png
Adeia to Release Third Quarter 2023 Financial Results on November 6, 2023
October 16, 2023 16:05 ET | Adeia Inc.
Adeia's third quarter earnings date annoucement
cmi_logo.png
[Latest] Global Contract Lifecycle Management Market Size/Share Worth USD 3.69 Billion by 2032 at a 12.33% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
October 11, 2023 14:00 ET | Custom Market Insights
Austin, TX, USA, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Contract Lifecycle Management Market Size, Trends and Insights By Deployment...